Home  >  Products  >  MLLT4 (myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4) Blocking Peptide (100ug)
MLLT4 (myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4) Blocking Peptide (100ug)

MLLT4 (myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MLLT4 antibody (Catalogue #: ARP34225_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP34225
Size: 100 ug
Weight: 74kDa
Gene: 4301
Format: Lyophilized powder
Target: AF6 is a Ras target that regulates cell-cell adhesions downstream of Ras activation. It is fused with MLL in leukemias caused by t(6;11) translocations.
Alternative names: RP3-470B24.4, AF-6, AF6, AFADIN, FLJ34371, RP3-431P23.3
See Full Product Listings >